Proposed Collection; Comment Request, 4151-4152 [06-704]
Download as PDF
<![CDATA[
4151
Federal Register / Vol. 71, No. 16 / Wednesday, January 25, 2006 / Notices
measurable goals for Federal Programs
that can be reported as part of the
budgetary process, thus linking funding
decisions with performance.
Performance measures for MCHB
discretionary grants were initially
approved in January 2003. Approval
from OMB is being sought to continue
programs, and will not apply to all
grantees. Furthermore, these measures
are based primarily on existing data,
thereby minimizing the response burden
consistent with program administration
and management needs.
The estimated response burden is as
follows:
the use of these measures. The number
of measures has been reduced with the
transfer of a program to the
Administration for Children and
Families. The remaining performance
measures are unchanged from those
approved in 2003. Some of these
measures are specific to certain types of
Form
Number of
respondents
Responses per
respondent
Total
responses
Burden per
response
Total burden
hours
Grant Report ....................................................
631
1
631
6
3,786
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to:
John Kraemer, Human Resources and
Housing Branch, Office of Management
and Budget, New Executive Office
Building, Room 10235, Washington, DC
20503.
Dated: January 19, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–893 Filed 1–24–06; 8:45 am]
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, call the HRSA Reports
Clearance Office on (301) 443–1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Proposed Project: The Health
Professions Student Loan (HPSL) and
Nursing Student Loan (NSL) Programs:
Forms (OMB No. 0915–0044): Extension
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The HPSL Program Provides longterm, low-interest loans to students
attending schools of medicine,
osteopathic medicine, dentistry,
veterinary medicine, optometry,
podiatric medicine, and pharmacy. The
NSL Program provides long-term, lowinterest loans to students who attend
eligible schools of nursing in programs
leading to a diploma in nursing, and an
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
Number of
respondents
Form
Deferment HRSA–519 .........................................................
AOR–HRSA–501 .................................................................
3,000
977
Total Burden .................................................................
Responses
per
respondent
associate degree, a baccalaureate degree,
or a graduate degree in nursing.
Participating HPSL and NSL schools are
responsible for determining eligibility of
applicants, making loans, and collecting
monies owed by borrowers on their
outstanding loans. The deferment form
(HRSA form 519) provides the schools
with documentation of a borrower’s
eligibility for deferment. The Annual
Operating Report (AORHRSA form 501)
provides the Federal Government with
information from participating and nonparticipating schools (schools that are
no longer granting loans but are
required to report and maintain program
records, student records, and repayment
records until all student loans are repaid
in full and all monies due the Federal
Government are returned) relating to
HPSL and NSL program operations and
financial activities.
The estimate of burden is as follows:
Total
responses
1
1
3,000
977
3,977
Hours per
responses
Total burden
hours
1 10
24
3,977
500
3,908
4,408
1 Minutes.
wwhite on PROD1PC61 with NOTICES
2 Hours.
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to:
John Kraemer, Human Resources and
Housing Branch, Office of Management
and Budget, New Executive Office
Building, Room 10235, Washington, DC
20503.
VerDate Aug<31>2005
18:26 Jan 24, 2006
Jkt 208001
Dated: January 19, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–894 Filed 1–24–06; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request
A Survey of Estimated Glomerular
Filtration Rate (GFR) Reporting
Practices of Clinical Laboratories.
Summary: In compliance with the
requirement of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
Frm 00053
Fmt 4703
Sfmt 4703
E:\FR\FM\25JAN1.SGM
25JAN1
4152
Federal Register / Vol. 71, No. 16 / Wednesday, January 25, 2006 / Notices
for the opportunity for public comment
on proposed data collection projects, the
National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK)
of the National Institutes of Health
(NIH) will publish periodic summaries
of proposed projects to be submitted to
the Office of Management and Budget
(OMB) for review and approval.
Proposed Collection: Title: A Survey
of Estimated GFR Reporting Practices of
Clinical Laboratories: Type of
Information Collection Request: New.
Need and Use of Information Collection:
This study will assess the level of U.S.
clinical laboratory reporting of
estimated GFR as a measure of kidney
function. This will be accomplished
through baseline and follow-up surveys
of a representative sample of clinical
laboratories in the U.S. Information will
be used to establish baseline data
necessary to measure an anticipated
increased in use of estimated GFR,
following the implementation of the
NKDEP’s communications and Lab
Working Group (LWG) activities
promoting use of estimated GFR for
patients at risk for kidney disease. The
LWG, whose members are experts in
their field, strongly believes that routine
reporting of estimated GFR will result in
a significant increase in early detection
of chronic kidney disease, therefore
enabling treatment that can slow or
prevent patients’ progression to kidney
failure. Frequency of Response: Baseline
survey only. Affected Public: Clinical
laboratory community. Type of
Respondents: Laboratory directors. The
annual reporting burden is as follow:
Estimated Number of Respondents:
Estimated
number of respondents
Type of respondents
Estimated
number of responses per
respondent
Average burden hours per
response
4,126
4,126
1.0
1.0
.083
.083
wwhite on PROD1PC61 with NOTICES
Clinical Laboratory Directors ............................................................................
Total ..........................................................................................................
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to responded, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
For Further Information Contact: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Elisa Gladstone,
MPH, Project Officer, Associate
Director, National Kidney Disease
Education Program, National Institute of
Diabetes and Digestive and Kidney
Diseases, National Institutes of Health,
Building 31, Center Dr., Room 9A06,
Bethesda, MD 20892, or call non-toll
free number (301) 435–8116 or e-mail
your request, including your address to,
gladstonee@niddk.nih.gov.
VerDate Aug<31>2005
18:26 Jan 24, 2006
Jkt 208001
Anticipate 4,126 completed surveys;
Estimated Number of Responses per
Respondent: Respondents will complete
one paper-and-pencil or online survey;
Average Burden Hours Per Response:
.083 hours [5 minutes]; and Estimated
Total Annual Burden Hours Requested:
342.46 hours. The annualized total cost
to respondents is estimated at
$11,759.10. (Note: Completing this
survey is similar to other data reporting
carried out by lab directors. Since lab
directors will be able to responded to
the survey within their usual workday,
this collection of information will not
cost labs.employers additional time and
money.) There are no Capital Costs to
report. There are no Operating or
Maintenance Costs to report.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: January 17, 2006.
Elisa H. Gladstone,
MPH, Project Officer, Associate Director,
National Kidney Disease Education Program,
National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of
Health.
[FR Doc. 06–704 Filed 1–24–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
National Institutes of Health,
Public Health Service, HHS.
AGENCY:
ACTION:
Notice.
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Annual total
burden hours
requested
342.46
342.46
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301/
496–7057; fax: 301/402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
Intraperitoneal Injection of
Pseudovirions Carrying a Toxin Leads
to Significantly Reduced Tumor Size
Michael M. Gottesman et al. (NCI)
U.S. Provisional Application filed 01
Dec 2005 (HHS Reference No. E–163–
2005/0–US–01)
Licensing Contact: Michelle A. Booden;
301/451–7337;
boodenm@mail.nih.gov
SV40-based pseudovirions show great
promise in the cancer gene therapy
field. SV40 vectors very efficiently
deliver genes such as anti-viral agents,
DNA vaccine, genes for
chemoprotection, suicide genes, and
antiangiogenic genes. The immediate
application for this technology is to
target plasmid DNA to cancerous cells
as a gene therapy treatment for various
human carcinomas. In previous studies,
NCI investigators Chava Kimchi-Sarfaty
and Michael Gottesman have
E:\FR\FM\25JAN1.SGM
25JAN1
]]>Agencies
[Federal Register Volume 71, Number 16 (Wednesday, January 25, 2006)]
[Notices]
[Pages 4151-4152]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-704]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment Request
A Survey of Estimated Glomerular Filtration Rate (GFR) Reporting
Practices of Clinical Laboratories.
Summary: In compliance with the requirement of section
3506(c)(2)(A) of the Paperwork Reduction Act of 1995,
[[Page 4152]]
for the opportunity for public comment on proposed data collection
projects, the National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK) of the National Institutes of Health (NIH) will
publish periodic summaries of proposed projects to be submitted to the
Office of Management and Budget (OMB) for review and approval.
Proposed Collection: Title: A Survey of Estimated GFR Reporting
Practices of Clinical Laboratories: Type of Information Collection
Request: New. Need and Use of Information Collection: This study will
assess the level of U.S. clinical laboratory reporting of estimated GFR
as a measure of kidney function. This will be accomplished through
baseline and follow-up surveys of a representative sample of clinical
laboratories in the U.S. Information will be used to establish baseline
data necessary to measure an anticipated increased in use of estimated
GFR, following the implementation of the NKDEP's communications and Lab
Working Group (LWG) activities promoting use of estimated GFR for
patients at risk for kidney disease. The LWG, whose members are experts
in their field, strongly believes that routine reporting of estimated
GFR will result in a significant increase in early detection of chronic
kidney disease, therefore enabling treatment that can slow or prevent
patients' progression to kidney failure. Frequency of Response:
Baseline survey only. Affected Public: Clinical laboratory community.
Type of Respondents: Laboratory directors. The annual reporting burden
is as follow: Estimated Number of Respondents: Anticipate 4,126
completed surveys; Estimated Number of Responses per Respondent:
Respondents will complete one paper-and-pencil or online survey;
Average Burden Hours Per Response: .083 hours [5 minutes]; and
Estimated Total Annual Burden Hours Requested: 342.46 hours. The
annualized total cost to respondents is estimated at $11,759.10. (Note:
Completing this survey is similar to other data reporting carried out
by lab directors. Since lab directors will be able to responded to the
survey within their usual workday, this collection of information will
not cost labs.employers additional time and money.) There are no
Capital Costs to report. There are no Operating or Maintenance Costs to
report.
----------------------------------------------------------------------------------------------------------------
Estimated
Estimated number of Average burden Annual total
Type of respondents number of responses per hours per burden hours
respondents respondent response requested
----------------------------------------------------------------------------------------------------------------
Clinical Laboratory Directors................... 4,126 1.0 .083 342.46
Total....................................... 4,126 1.0 .083 342.46
----------------------------------------------------------------------------------------------------------------
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the function of the agency,
including whether the information will have practical utility; (2) The
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) Ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) Ways to minimize
the burden of the collection of information on those who are to
responded, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
For Further Information Contact: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact Elisa Gladstone, MPH, Project Officer, Associate
Director, National Kidney Disease Education Program, National Institute
of Diabetes and Digestive and Kidney Diseases, National Institutes of
Health, Building 31, Center Dr., Room 9A06, Bethesda, MD 20892, or call
non-toll free number (301) 435-8116 or e-mail your request, including
your address to, gladstonee@niddk.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Dated: January 17, 2006.
Elisa H. Gladstone,
MPH, Project Officer, Associate Director, National Kidney Disease
Education Program, National Institute of Diabetes and Digestive and
Kidney Diseases, National Institutes of Health.
[FR Doc. 06-704 Filed 1-24-06; 8:45 am]
BILLING CODE 4140-01-M
